75A-31148-33223
4 vaccinations
3 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 981 / WA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-27
-
2021-01-04
Dose 2 — Pfizer-BioNTech
- 2021-01-04
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-20
- 2021-01-25
- 2021-02-01
- 2021-02-10
- 2021-02-15
- 2021-04-05
-
2021-07-07
Survey response — 6 months, dose 2MedDRA: Foetal growth restriction — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Received diagnosis of severe fetal growth restrictionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-07
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-09
-
2021-07-09
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-12
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-01-04
Survey response — 12 months, dose 2MedDRA: Ear discomfort, Nasopharyngitis, Throat irritation — Feeling: Fair · Be unable to work or attend schoolFree text: Scratchy throat, clogged ears; feels like the beginning of a cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid-19MedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Dose 4 — Pfizer-BioNTech
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-27
- 2022-11-02
- 2022-12-21
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-04 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-07 | Successful 2021-07-09 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 6 months, dose 2
Symptoms: Received diagnosis of severe fetal growth restriction
Release 10 — 12 months, dose 2
Symptoms: Scratchy throat, clogged ears; feels like the beginning of a cold.
Release 11 — 6 months, dose 3
Symptoms: Covid-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Ear discomfort | · | · | ✓ |
| SD | Foetal growth restriction | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release